ARV Treatment: Special Focus
Back to Main Page
ARV Treatment: Special Focus Back to Main Page |
|
Dear Dr Witzel: > > How are you? > > AS another topics for conference I suggest: > > a) the impact of patent laws in drug prices and accessiblity in developing countries > > b) the consequences of the so called cost-effectiveness analysis in the reality of countries. I think that these analysis are mainly used to deny demands rather that satisfy them, with a flavour of technicity. How are they used? Are they only effective to manage misery while not looking at other expenditures (military, corruption, etc) ? c) ANother topic is cost effectiveness of AIDS treatment under patent laws which only benefit developed countries vs under other patent laws or no other patent laws. d) COSt effectiveness of the implementation of IMF guidelines in education and health and unemployment e) the consequences of the restricted areas priorities policy I''l try to explain my point: When the so called technicians analyse " priorities", they do this in restricted areas: AIDS patients vs kidney patients; AIDS prevention vs AIDS assistance: they won't analyse AIDS treatment versus help to frauded banks; or even hunger vs help to frauded banks; or increasing health budgets versus not increasing them as a way to save lives. One of the limitations of this perspective is exemplified by DOTS (directly observed treatment strategy): of course so called the technicians would say , mimmicking the ARV arguments "giving TB drugs to people in developing countries is not cost effective because they are not adherent and this can produce multidrug resistant strains, much more expensive to manage." The answer came not from people concerned in saving money, but in saving lives, and it is called DOTS. It is a way to increase adherence to TB treatment. Could we put the stress in saving lives rather than in saving money? Or our tools are not designed for these purposes? How does this cost effectiveness analysis insert in legal structures, for example those which provide universal treatment, or even private insurances policies? Are these technicians trying to help societies to fulfill these laWS when they exist or not? > > Thank you for your attention > > Jorge |
Responses:
 AIDS Economics Home Page |
ARV Treatment: Special Focus Back to Main Page |